Drreddys Laboratories | Betriebsaufwand



Operating Expenses Veränderung Datum
ANI Pharmaceuticals USD 196.2M 25.27M 2025-06
Aurora Cannabis CAD 51.98M 31.53M 2024-12
Bayer EUR 10.73B 688M 2025-06
Canopy Growth CAD 98.58M 10.03M 2024-12
Cipla INR 54.32B 687.8M 2025-06
Corcept Therapeutics USD 167.76M 13.96M 2025-06
Drreddys Laboratories INR 64.87B 2.26B 2024-12
GlaxoSmithKline GBP 5.96B 663M 2025-06
Hikma Pharmaceutical USD 1.31B 63M 2024-12
Lonza CHF 3.09B 564M 2024-12
Novartis USD 9.97B 1.02B 2025-06
Pacira USD 170.87M 3.93M 2025-06
Prestige Brands USD 177.77M 30.32M 2025-06
Richter Gedeon HUF 153.02B 2.72B 2024-09
Sun Pharmaceuticals INR 104.14B 1.45B 2025-06
Supernus Pharmaceuticals USD 153.31M 892K 2025-06
Teva Pharmaceutical Industries USD 3.28B 95M 2025-06


Drreddys Laboratories Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.